期刊文献+

BED方法监测吸毒人群HIV新发感染率 被引量:4

Surveillance of New HIV Infections in Drug Users by BED Method
原文传递
导出
摘要 目的监测估计四川省吸毒人群艾滋病(HIV)新发感染率。方法收集2007-2012年四川省13个吸毒人群监测哨点HIV筛查阳性样本,进行蛋白印迹法(Western Blot,简称WB)确证检测,对其中阳性样本排除既往感染后,进行BED方法检测,进而计算各地区和全省新发感染率。结果 2007-2012年四川省吸毒哨点HIV新发感染率分别为7.62%、3.45%、2.92%、1.57%、1.52%和1.17%,其中累计存活HIV/AIDS大于2万(人群感染率大于5‰)的高流行地区连续6年新发感染率为24%、7.81%、15.56%、8.05%、10.12%和6.21%。结论四川省吸毒人群HIV新发感染率逐年下降,但是高流行地区HIV流行形式依然严峻,可以认为全省综合防治工作已取得相当成效,但重点地区仍需持续加强工作力度。 Objective To survey and estimate the incidence of HIV in injection drug use (IDU) population in Sichuan province. Methods Preliminary screened HIV positive samples of 13 IDU sentinels during 2007 to 2012 were collected and tested by Western Blot (WB). The positive samples were assayed using the BED method. The incidence of HIV in IDU sentinel populations were further estimated in each district and across the province. Results The HIV incidences during 2007 to 2012 in IDU sentinels in Sichuan were 7.62%, 3.45% , 2. 92% , 1.57% , 1.52% and 1.17% , respectively. The incidences of the severely endemic areas (with infection rate over 5%~) were correspondingly 24%, 7.81%, 15.56%, 8.05%, 10. 12% and 6. 21%. Conclusion The HIV incidences in IDU population of Sichuan have decreased year after year; nevertheless, the epidemic situation is still rigorous in high prevalence areas, which requires strengthened prevention and control efforts.
出处 《预防医学情报杂志》 CAS 2014年第12期991-994,共4页 Journal of Preventive Medicine Information
关键词 BED 人类免疫缺陷病毒 吸毒人群 新发感染率 BED HIV injection drug user incidence
  • 相关文献

参考文献5

二级参考文献44

  • 1马瑛 李明正.首次在我国吸毒人群中发现艾滋病毒感染者[J].中华流行病学杂志,1990,11:184-185.
  • 2Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA, 1998, 280 (1) : 42-48.
  • 3Centers for Disease Control and Prevention. HIVIAIDS Surveillance Report, 2006.Vo1.18. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.Available at: http ://www.cdc.gov/hiv/topics/surveillance/ resources/reports/.
  • 4Centers for Disease Control and Prevention. Using the BED HIV-1 Capture EIA Assay to Estimate Incidence Using STARHS in the Context of Surveillance in the United States. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007 : 10. Available at: http://www.cdc. gov/hiv/topics/HIV/AIDS Science Facts/.
  • 5Lee LM, Mckenna MT. Monitoring the incidence of HIV infection in United States. Public Health Rep, 2007, 122 Suppl : S72-79.
  • 6Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res, 2005, 121 (4): 510-518.
  • 7Centers for Disease Control. HIV Incidence Surveillance: Estimating National and Local HIV Incidence Using a Population-based Serologic Method to Detect Recent HIV-1 Infection. Atlanta, March 20, 2005. Available at: www.cdc.gov/ NCHSTP/.
  • 8Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses, 2002,18(4) : 295-307.
  • 9Hall HI, Song R, Rhodes P, et al. Estimation of HIV Incidence in the United States. JAMA, 2008,300 (5) : 520-529.
  • 10Jiang Y, Wang M, Ni M, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS, 2007, 21 (Suppl 8) :S47-51.

共引文献17

同被引文献34

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部